3Miyaka N,Sato K,Hashimoto J.Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium[J].Clin lmmuad lmmamtopathd,1999,52(2):238-247.
4Vane JR,Botting RM. Mechanism of action of anti-inflammatory drugs[J]. Scand J Rheum atol,1996,102(Suppl) :9 - 21.
5Cannon G, Caldwell J, Holt P, et al. MK - 0966, a specific COX - 2 inhibitor, has clinical efficacy comparable to diclofenac in the treatment of knee and hip osteoarthritis in a 26 week controlled clinical trial[ J ]. Arthritis Rheum, 1998,41 ( Suppl 9) : 196.
6Geis GS,Stead H, Morant S, et al. Efficacy and safety of celecoxib, a specific COX - 2 inhibitor, in patients with rheumatioid arthritis [J]. Arthritis Rheum, 1998,41(Suppl 9) :316.
7Roberts WN, Babcok EA, Breitbach SA, et al. Corticoid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty [J]. J Rheumatol, 1996,23(6) : 1001 - 1004.
8Pearce GJ, Chikanza IC. Targeting tumor necrosis factor in the treatment of rheumatoid arthritis[J]. Bio Drugs,2001,15(3) :139 - 149.
9St Clair EW. Infliximab treatment for rheumatic disease: clinical and radiological efficacy[ J ]. Ann Rheum Dis, 2002,61 (Suppl 2) :167 - 169.
10Arend WP. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin- 1 receptor antagonist [ J ]. Semin Arthritis Rheum,2001,30(5 Suppl 2) :1 - 6.
